RNWL
INTERNATIONAL REGISTRATION RENEWED
11/25/2024
Back to search
Official data from USPTO
TAKATA PHARMACEUTICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
11/25/2024
Trademark type
Combined
Nice classes
5
Filing date
11/25/2014
Registration date
03/15/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/30/2022
Last transaction
10/28/2022
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
JP
Examiner
TARCU,CATHERINE L
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "TAKATA PHARMACEUTICAL" written in stylized font. The letters "T" and the letter "K" in the word "TAKATA" appear in dark blue and the letters "A" in the word appear in light blue. The word "PHARMACEUTICAL" appears in dark blue. To the left of the wording is an image of a flower that has one half in pink and one half in blue that fades from light blue to dark blue. A half circle design that fades from light blue to dark blue appears through the flower. The flower has a white center and white lines.
Holders and representatives
Holders
TAKATA Pharmaceutical Co., Ltd.
Representatives
Kumiko Ide Westerman, Hattori, Daniels & Adrian LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsanti-cancer drugs and antibiotics; Preparations for destroying vermin; fungicides; herbicides; nutritional additives for medical purposes for use in food and dietary supplements for human consumption; medicinal tonics and substitutes therefor in the nature of nutritional food and drink additives containing vitamins and nutrients for health and medical purposes; dietary supplements for humans
Publications
History of USPTO decisions and trademark events.
38 publications found
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
05/30/2023
C71T
CANCELLED SECTION 71
09/30/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/15/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/24/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/29/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/08/2016
FIMP
FINAL DISPOSITION PROCESSED
07/08/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/15/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
03/15/2016
GPNX
NOTIFICATION PROCESSED BY IB
01/04/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/29/2015
PUBO
PUBLISHED FOR OPPOSITION
12/29/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/16/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/16/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/09/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/23/2015
ALIE
ASSIGNED TO LIE
11/19/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/06/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
10/06/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/06/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
10/06/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/06/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/11/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/11/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/11/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/11/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/21/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/21/2015
RFNT
REFUSAL PROCESSED BY IB
06/02/2015
MAFR
APPLICATION FILING RECEIPT MAILED
05/16/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/14/2015
RFRR
REFUSAL PROCESSED BY MPU
05/14/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/14/2015
CNRT
NON-FINAL ACTION WRITTEN
05/13/2015
DOCK
ASSIGNED TO EXAMINER
05/12/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/12/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/07/2015
Continuous trademark protection
Get notified about every new filing that threatens TAKATA PHARMACEUTICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.